Integrated Member (PhD)
Research Line: L4 - Patient and Population Outcomes Research
Bárbara Peleteiro has a Degree in Biochemistry (Faculty of Sciences, University of Porto, 2004), a Master in Epidemiology (Faculty of Medicine, University of Porto, 2007) and a PhD in Public Health (Faculty of Medicine, University of Porto, 2011).
She is currently an Epidemiologist at São João Hospital University Centre in Porto (since 2017), an Invited Assistant Professor in Epidemiology at the Faculty of Medicine, University of Porto (since 2015), and a Post-Doctoral Researcher at the Institute of Public Health of the University of Porto (since 2012).
She has supervised 1 PhD thesis, 14 Master theses and co-supervised 1 PhD thesis and 1 Master thesis. She is currently supervising 1 PhD thesis and 1 Master thesis and is co-supervisor of 1 PhD thesis. She is the managing editor of the Porto Biomedical Journal (since 2016) and a member of the BMC Gastroenterology editorial board (since 2014), becoming a senior member of the latter in 2020.
She was awarded with the Enrico Anglesio Prize in 2010. She has participated in 2 projects funded at national level and has joined the Internalstional consortium StoP. She has published many papers in Internalstional peer-reviewed journals, most of them as a first author, and book chapters, as well as abstracts in conferences.
Her main research interests are the ascertainment of the impact of disease burden associated with cancer, both by the analysis of secondary information on health and by the use of original data, integrating the ITR Lab “Individual- and system-level factors towards the attainment of high value health care”.
J Cancer Res Clin Oncol ., 2022 Jul 29. doi: 10.1007/s00432-022-04228-2. Online ahead of print.
J Breast Cancer, 2022 Mar 19. doi: 10.1007/s12282-022-01349-x. Online ahead of print.
Cancer Epidemiol Biomarkers Prev, 2022 Jan;31(1):200-209. doi: 10.1158/1055-9965.EPI-21-0402. Epub 2021 Nov 2.
J Breast Cancer, 2021 Dec;24(6):542-553. doi: 10.4048/jbc.2021.24.e45. Epub 2021 Oct 20.
Antimicrob Resist Infect Control, 2021 Sep 30;10(1):139. doi: 10.1186/s13756-021-01007-5.
Sci Rep, 2021 Jul 15;11(1):14546. doi: 10.1038/s41598-021-93868-4.
BMC Health Serv Res, 2021 Apr 21;21(1):372. doi: 10.1186/s12913-021-06389-1.
J Glaucoma, 2021 Mar 5. doi: 10.1097/IJG.0000000000001825. Online ahead of print.
Front Public Health, 2020 Sep 11;8:505. doi: 10.3389/fpubh.2020.00505. eCollection 2020.
Front Public Health, 2020 Aug 21;8:392. doi: 10.3389/fpubh.2020.00392. eCollection 2020.
J Public Health (Oxf), 2020 Aug 5:fdaa118. doi: 10.1093/pubmed/fdaa118. Online ahead of print.
Int J Cancer, 2020 Jun 11. doi: 10.1002/ijc.33134. Online ahead of print.
Front Public Health, 2020 Feb 21;8:15. doi: 10.3389/fpubh.2020.00015. eCollection 2020.
Surg Oncol, 2020 Mar;32:108-114. doi: 10.1016/j.suronc.2019.11.008. Epub 2019 Nov 25.
J Med Screen, 2019 Dec 22:969141319891456. doi: 10.1177/0969141319891456. [Epub ahead of print]
Environ Res, 2019 Oct 1;179(Pt A):108780. doi: 10.1016/j.envres.2019.108780. [Epub ahead of print]
Int J Cancer, 2019 Oct 4. doi: 10.1002/ijc.32707. [Epub ahead of print]
Eur J Cancer Prev, 2019 Sep;28(5):390-396. doi: 10.1097/CEJ.0000000000000471.
Paediatr Perinat Epidemiol, 2019 Jul;33(4):249-259. doi: 10.1111/ppe.12562.
